The Library

RPB4 and pathogenesis of diabetes

Tools

McTernan, P. G. (Philip G.) and Kumar, Sudhesh. (2007) RPB4 and pathogenesis of diabetes. Journal of Clinical Endocrinology & Metabolism , Vol.92 (No.7). pp. 2430-2432. ISSN 0021-972x

Preview

PDF
WRAP_Kumar_2007_-_Post-print_version_-_Retinol_binding.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (140Kb)

Official URL: http://dx.doi.org/10.1210/jc.2007-1054

Item Type:	Journal Article
Alternative Title:	Retinol binding protein 4 and pathogenesis of diabetes
Subjects:	R Medicine > RC Internal medicine
Divisions:	Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	Diabetes, Fat cells
Journal or Publication Title:	Journal of Clinical Endocrinology & Metabolism
Publisher:	Endocrine Society
ISSN:	0021-972x
Date:	2007
Volume:	Vol.92
Number:	No.7
Page Range:	pp. 2430-2432
Identification Number:	10.1210/jc.2007-1054
Status:	Peer Reviewed
Access rights to Published version:	Open Access
Description:	Version accepted by publisher (post-print, after peer review, before copy-editing)
References:	1. Harte AH, McTernan PG, Chetty R, Coppack S, Katz J, Smith SA, Kumar S. 2005 Insulin mediated upregulation of the Renin Angiotensin System in Human Subcutaneous Adipocytes is Reduced by Rosiglitazone. Circulation 111(15):1954-61 2. Rajala MW, Scherer PE. 2003 Minireview: the adipocyte: at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765–3773 3. Beetham R, Silver A, Dawnay A. 1987 Urinary albumin and retinol-binding protein in diabetes. Clin Chem 33(5):713. 4. Noy N. 2000 Retinoid-binding proteins: mediators of retinoid action. Biochem J 348: 481-495 5. Attard-Montalto, S.; Evans, N.; Sherwood, R. A. Carotenaemia with low vitamin A levels and low retinol-binding protein. J. Inherit. Metab. Dis. 15: 929-930, 1992 6. Janke J, Engeli S, Boschmann M, Adams F, Böhnke J, Luft FC, Sharma AM, Jordan J. 2006 Retinol-Binding Protein 4 in Human Obesity Diabetes 55:2805-2810 7. Abel ED, Peronie O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB. 2001 Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:672–673 8. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani KO, Quadro L and Kahn BB. 2005 Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436, 356-362 9. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. 2006 Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 15;354(24):2552-63 10. Chambon, P. 1996 A decade of molecular biology of retinoic acid receptors. FASEB J 10:940−954 11. S Zanardi, D Serrano, A Argusti, M Barile, M Puntoni, A Decensi 2006 Clinical trials with retinoids for breast cancer chemoprevention Endocrine-Related Cancer 13 (1) 51-68 12. McTernan PG, Kusminski CM, Kumar S. 2006 Resistin. Curr Opin Lipidol. 17(2):170-5 13. Stephens JM, Vidal-Puig AJ. 2006 An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity. Curr Opin Lipidol 17(2):128-31 14. Graham TE, Wason CJ, Bluher M, Kahn BB. 2007 Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia 50(4):814-23. Epub 2007 Feb 9 15. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, Rashidi AA, McGehee RE Jr, Fried SK, Kern PA. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation and response to pioglitazone, J Clin Endocrinol Metab 92(6): 16. Bogacka I, Xie H, Bray GA, Smith SR. 2004 The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Diabetes Care 27(7):1660-7 17. McTernan PG, Fisher FM, Valsamakis G, Chetty R, Harte A, McTernan CL, Clark PM, Smith SA, Barnett AH, Kumar S. 2003 Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab. 88(12):6098-106 18. Varma V, Yao-Borengasser A, Rasouli N, Bodles AM, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, McGehee RE Jr, Fried SK, Kern PA. 2007 Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab. 2007 Feb;92(2):666-72. Epub 2006 Nov 7 19. Hammarstedt A, Pihlajamaki J, Rotter Sopasakis V, Gogg S, Jansson PA, Laakso M, Smith U. 2006 Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 91(3):1181-4. Epub 2006 Jan 4 20. Haider DG, Schindler K, Mittermayer F, Muller M, Nowotny P, Rieger A, Luger A, Ludvik B, Wolzt M. 2007 Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients. Clin Pharmacol Ther. 2007 Apr;81(4):580-5. Epub 2007 Jan 18. Erratum in: Clin Pharmacol Ther. 2007 Apr;81(4):611
URI:	http://wrap.warwick.ac.uk/id/eprint/157